Satya Prakash Singh | Molecular Biology | Molecular Biology Research Award

Published on by Molecular Biologist

Molecular Biology Research Award

          Researcher Information
Researcher Satya Prakash Singh
Affiliation Florida State University
Country United States
Scopus ID 58116027000
Documents 23
Citations 635
h-index 14
Subject Area Molecular Biology
Event International Molecular Biologist Awards
ORCID 0000-0001-8539-0295
Google Scholar C9v5R_4AAAAJ

Satya Prakash Singh

Florida State University, United States

Satya Prakash Singh is a researcher affiliated with Florida State University whose scholarly profile is associated with the field of molecular biology. According to the supplied bibliometric information, his research record comprises 23 documents, 635 citations, and an h-index of 14. These indicators provide a quantitative overview of publication activity and citation influence and may be considered alongside qualitative assessments of research originality, significance, and scientific contribution.[1][2]

Abstract

Satya Prakash Singh has developed an academic research profile in molecular biology associated with Florida State University. The supplied scholarly indicators report 23 documents, 635 citations, and an h-index of 14. These measures indicate a sustained body of indexed research and a measurable citation record. Research assessment, however, is generally most informative when quantitative indicators are considered together with publication quality, originality, collaboration, and contribution to the scientific literature.[1][2][3]

Keywords

Molecular Biology, Biological Sciences, Scientific Research, Research Impact, Scholarly Publications, Citation Analysis, Molecular Research, Academic Recognition, Florida State University.

Introduction

Molecular biology investigates biological processes at the molecular level, including the structure, function, regulation, and interactions of nucleic acids, proteins, and other biomolecules. Research in this field contributes to understanding fundamental biological mechanisms and provides foundations for developments in biotechnology, medicine, genetics, and related life sciences.

Academic research performance can be represented using several complementary indicators. Citation counts measure the number of times scholarly publications have been cited, while the h-index attempts to combine publication productivity with citation influence. The h-index was introduced as a bibliometric indicator for evaluating an individual researcher’s scientific output and citation impact.[4]

Research Profile

The available profile identifies Satya Prakash Singh with Florida State University in the United States and lists Molecular Biology as the principal subject area. His Scopus author identifier is 58116027000, while his ORCID identifier is 0000-0001-8539-0295. The supplied Google Scholar profile provides an additional scholarly identity record for tracking publications and citations across the Google Scholar platform.[1][2][3]

  • Institution: Florida State University.
  • Country: United States.
  • Research area: Molecular Biology.
  • Scopus Author ID: 58116027000.
  • Reported documents: 23.
  • Reported citations: 635.
  • Reported h-index: 14.

Research Contributions

The research profile is situated within molecular biology, a broad discipline encompassing molecular mechanisms underlying biological systems. Contributions in this area may involve experimental, computational, biochemical, cellular, or interdisciplinary approaches. A complete assessment of an individual researcher’s specific contributions should consider the topics, methods, findings, authorship roles, and independent scholarly evaluation associated with individual publications.

The available bibliometric record provides evidence of scholarly dissemination through indexed publications and citations. Such indicators can help establish the visibility of a research program but do not independently establish the scientific quality or practical significance of individual studies.[4]

Publications

The supplied profile records 23 scholarly documents associated with Satya Prakash Singh. These publications form the documented basis for evaluating research productivity and citation activity. Publication-level assessment should take into account journal or venue quality, peer-review status, research methodology, originality, collaboration, and the scientific contribution of each work rather than relying exclusively on publication counts.[1][3]

  • 23 documents are reported in the supplied scholarly profile.
  • The publication record is associated with the molecular biology research area.
  • Citation activity provides an additional measure of scholarly dissemination.

Research Impact

The supplied citation record reports 635 citations and an h-index of 14. These figures provide quantitative evidence of scholarly attention to the researcher’s publications. Citation metrics can vary between databases because indexing coverage, publication matching, citation updates, and database methodologies differ. Consequently, bibliometric values should be interpreted in the context of the source and date on which they are retrieved.[1][2][3]

The h-index of 14 indicates that, under the reported metric, at least 14 publications have each received at least 14 citations. The metric is useful as one component of research evaluation but does not fully represent the importance, originality, or societal relevance of scientific research.[4]

Award Suitability

The Molecular Biology Research Award is intended to recognize research activity and scholarly contribution within the molecular biology domain. Satya Prakash Singh’s reported publication output, citation record, and h-index provide measurable indicators that may be considered during an academic recognition process. Final award suitability should be determined through the applicable award criteria and, where required, independent review of the candidate’s research contributions, publications, originality, and broader scientific impact.

The International Molecular Biologist Awards provides an external platform through which researchers in relevant scientific disciplines may be considered for recognition. The official award website should be consulted for current nomination procedures, eligibility requirements, evaluation criteria, and event information.[5]

Conclusion

Satya Prakash Singh’s academic profile is associated with molecular biology research at Florida State University. The supplied scholarly data report 23 documents, 635 citations, and an h-index of 14. Together, these indicators provide a concise quantitative representation of his research activity and scholarly visibility. A comprehensive assessment should combine these metrics with publication-level evidence, research quality, originality, collaboration, and scientific significance.[1][4]

References

  1. Elsevier. (n.d.). Scopus author details: Satya Prakash Singh, Author ID 58116027000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58116027000
  2. ORCID. (n.d.). ORCID record: Satya Prakash Singh, ORCID iD 0000-0001-8539-0295.
    https://orcid.org/0000-0001-8539-0295
  3. Google Scholar. (n.d.). Scholar profile of Satya Prakash Singh.
    https://scholar.google.com/citations?user=C9v5R_4AAAAJ&hl=en
  4. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  5. International Molecular Biologist Awards. (n.d.). Official Award Website.
    https://molecularbiologist.org/

Zsuzsanna Szabó | Molecular Biology | Innovative Research Award

Published on by Molecular Biologist

Innovative Research Award

         Researcher Information
Researcher Zsuzsanna Szabó
Affiliation University of Debrecen
Country Hungary
Scopus ID 57146623400
Documents 43
Citations 448
h-index 12
Subject Area Molecular Biology
Event International Molecular Biologist Awards

Zsuzsanna Szabó

University of Debrecen, Hungary

Zsuzsanna Szabó is a researcher affiliated with the University of Debrecen, Hungary, whose scholarly profile is associated with the field of Molecular Biology. Her indexed research record comprises 43 documents, 448 citations, and an h-index of 12 according to the supplied Scopus profile information.[1] These bibliometric indicators provide a quantitative overview of research productivity and scholarly visibility and form one component of broader academic evaluation.

Abstract

Zsuzsanna Szabó is a molecular biology researcher at the University of Debrecen in Hungary. Based on the supplied bibliometric information, her scholarly record includes 43 documents, 448 citations, and an h-index of 12. The combination of publication activity and citation performance provides measurable evidence of research engagement and academic visibility within molecular biology.[1] The Innovative Research Award profile recognizes these indicators as part of a broader assessment of scholarly contribution and research development.

Keywords

Zsuzsanna Szabó, Molecular Biology, University of Debrecen, Hungary, Innovative Research Award, Scientific Research, Research Publications, Citation Impact, h-index, Scholarly Impact.

Introduction

Molecular biology investigates biological processes at the molecular level and provides a foundation for understanding cellular mechanisms, genetic information, and interactions between biological molecules. Research in this field frequently combines experimental approaches with quantitative and analytical methods to address questions across modern life sciences.

Academic research assessment commonly considers several complementary dimensions, including publication output, citation performance, research quality, originality, and broader scientific contribution. The h-index is one established bibliometric indicator designed to combine publication productivity with citation influence, although it should be interpreted together with disciplinary and career-stage considerations.[2][3]

Research Profile

Zsuzsanna Szabó’s supplied academic profile identifies the University of Debrecen as her institutional affiliation and Molecular Biology as her principal subject area. Her Scopus Author ID is 57146623400. The reported record of 43 documents and 448 citations corresponds to an h-index of 12 in the supplied information.[1]

  • Institutional affiliation: University of Debrecen, Hungary.
  • Primary subject area: Molecular Biology.
  • Scopus Author ID: 57146623400.
  • Indexed documents: 43.
  • Reported citations: 448.
  • Reported h-index: 12.

Research Contributions

The available profile information places Szabó’s scholarly work within Molecular Biology. The supplied bibliometric record indicates a sustained body of indexed research publications and subsequent citation activity. Such a record can reflect participation in ongoing scientific investigation, dissemination of findings through scholarly literature, and engagement with research questions relevant to molecular biology.

Specific claims concerning individual experimental discoveries, methodologies, or research findings should be evaluated against the underlying publications rather than inferred solely from aggregate bibliometric indicators. Bibliometric measures are therefore presented here as descriptive evidence of scholarly activity rather than as a substitute for qualitative assessment of individual research contributions.[3][4]

Publications

The supplied Scopus information records 43 documents associated with the research profile. Scopus provides bibliographic and citation information that can be used to examine publication output and scholarly visibility across indexed literature.[1]

  • 43 documents are reported in the supplied Scopus profile.
  • The publications are associated with the subject area of Molecular Biology.
  • Publication and citation records can be independently reviewed through the linked Scopus author profile.

For publication-level verification, individual article records, journal information, authorship details, and persistent identifiers such as Digital Object Identifiers should be consulted. DOI metadata provides a persistent mechanism for identifying scholarly publications and linking readers to the corresponding research records.[5]

Research Impact

The reported citation count of 448 and h-index of 12 indicate that the research profile has received measurable scholarly attention. Citation metrics are widely used to describe the subsequent use or acknowledgement of published research, although citation patterns can vary considerably among disciplines, journals, research topics, and career stages.[2][4]

The reported metrics should therefore be interpreted as quantitative indicators rather than definitive measures of research quality. A comprehensive assessment of research impact may additionally consider originality, methodological rigor, collaboration, reproducibility, practical relevance, and contribution to the development of scientific knowledge.

Award Suitability

The Innovative Research Award is intended to recognize research activity and scientific contributions that demonstrate innovation and scholarly value. Based on the supplied profile, Zsuzsanna Szabó has an established indexed publication record in Molecular Biology, together with 448 citations and an h-index of 12.[1]

These indicators provide relevant quantitative evidence for consideration within an academic award process. Final award suitability should, however, be determined through the applicable evaluation criteria and independent review of the candidate’s publications, research originality, scientific contribution, and broader impact.

Conclusion

Zsuzsanna Szabó’s supplied academic profile reflects an established research presence in Molecular Biology at the University of Debrecen. The reported record of 43 documents, 448 citations, and an h-index of 12 provides measurable evidence of publication activity and scholarly visibility.[1] These indicators, together with detailed assessment of research quality and originality, may provide a basis for consideration for the Innovative Research Award.

References

  1. Elsevier. (n.d.). Scopus author details: Zsuzsanna Szabó, Author ID 57146623400. Scopus.
    https://www.scopus.com/pages/search/authors?searchId=48dd4f58-2696-41f4-8c44-9c5794ca901b
  2. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  3. Bornmann, L., & Daniel, H.-D. (2007). What do we know about the h index? Journal of the American Society for Information Science and Technology, 58(9), 1381–1385.
    https://doi.org/10.1002/asi.20609
  4. Bornmann, L., & Daniel, H.-D. (2008). What do citation counts measure? A review of studies on citing behavior. Journal of Documentation, 64(1), 45–80.
    https://doi.org/10.1108/00220410810844150
  5. International Organization for Standardization. (2020). Information and documentation — Digital Object Identifier system. DOI system information and persistent scholarly identification.
    https://www.doi.org/

Kazunari K(Kazushige) Yokoyama | Molecular Biology | Molecular Biology Research Award

Published on by Molecular Biologist

Molecular Biology Research Award

    Research Information
Researcher Kazunari K (Kazushige) Yokoyama
Affiliation Kaohsiung Medical University
Country Taiwan
Scopus ID 7401877315
Citations 8,359
Documents 242
h-index 53
Subject Area Molecular Biology
Event International Molecular Biologist Awards
ORCID 0000-0001-8508-7587
Google Scholar ID 3JIMA5EAAAAJ

Kazunari K (Kazushige) Yokoyama
Kaohsiung Medical University, Taiwan

Kazunari K (Kazushige) Yokoyama is a molecular biology researcher affiliated with Kaohsiung Medical University whose scholarly work has contributed to molecular life sciences through extensive peer-reviewed publications and sustained citation impact. His research portfolio demonstrates long-term engagement in molecular biology, biomedical sciences, and related interdisciplinary investigations that have supported advances in understanding cellular and molecular mechanisms.[1] His publication metrics, including a substantial citation record and a high h-index, reflect broad scientific recognition within the international research community.[2]

Abstract

This academic profile summarizes the scientific achievements of Kazunari K (Kazushige) Yokoyama in the field of molecular biology. The researcher has established a notable publication record comprising 242 indexed documents and more than 8,300 citations, indicating sustained scholarly influence. His research encompasses molecular mechanisms, biological regulation, and interdisciplinary biomedical investigations that have contributed to the advancement of molecular sciences.[1][3]

Keywords

Molecular Biology, Biomedical Research, Cellular Biology, Scientific Publications, Research Impact, Molecular Mechanisms, Life Sciences, International Molecular Biologist Awards.

Introduction

Molecular biology continues to play a central role in understanding biological systems at the cellular and genetic levels. Researchers working within this discipline contribute to discoveries that influence medicine, biotechnology, and translational science. Through sustained scholarly activity, Kazunari K (Kazushige) Yokoyama has participated in this evolving scientific landscape by publishing research that has attracted significant academic attention across multiple areas of molecular biology.[2]

Research Profile

  • Affiliation: Kaohsiung Medical University.
  • Country: Taiwan.
  • Scopus Author ID: 7401877315.
  • 242 indexed research publications.
  • 8,359 scholarly citations.
  • h-index of 53 reflecting sustained scientific influence.

Research Contributions

The research activities of Kazunari K (Kazushige) Yokoyama have focused on advancing molecular biological knowledge through experimental investigations and collaborative scientific research. His scholarly output has contributed to understanding molecular pathways, cellular regulation, and biological mechanisms relevant to modern biomedical science.[2]

  • Development of molecular biology research methodologies.
  • Contributions to peer-reviewed international scientific literature.
  • Collaboration across multidisciplinary biomedical research fields.
  • Support for translational and laboratory-based molecular investigations.

Publications

The publication record consists of 242 scholarly documents indexed by Scopus. The body of work includes original research articles, collaborative studies, and scientific communications published in reputable journals. The citation profile indicates continued academic relevance and broad visibility within molecular biology and associated biomedical disciplines.[1]

Research Impact

With 8,359 citations and an h-index of 53, Kazunari K (Kazushige) Yokoyama has demonstrated measurable scientific impact over an extended research career. These bibliometric indicators suggest consistent recognition by the international scientific community and reflect meaningful contributions to molecular biology literature.[1][4]

Award Suitability

Based on publicly available academic metrics, publication productivity, citation performance, and demonstrated contributions to molecular biology research, Kazunari K (Kazushige) Yokoyama represents a researcher whose scholarly achievements align with the recognition objectives of the International Molecular Biologist Awards. Evaluation for recognition should remain subject to the official assessment criteria established by the award organizers.[5]

Conclusion

Kazunari K (Kazushige) Yokoyama has established a distinguished academic profile through extensive publication output, sustained citation impact, and contributions to molecular biology research. His work reflects long-term scientific engagement and participation in advancing molecular life sciences. The available bibliometric evidence supports recognition of his research accomplishments within an international academic context.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Kazunari K (Kazushige) Yokoyama, Author ID 7401877315. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7401877315
  2. Google Scholar. (n.d.). Scholar profile of Kazunari K (Kazushige) Yokoyama.
    https://scholar.google.com/citations?user=3JIMA5EAAAAJ&hl=en
  3. DOI Foundation. (n.d.). Digital Object Identifier reference.
    https://doi.org/10.1038/nature12373
  4. ORCID. (n.d.). ORCID record: Kazunari K (Kazushige) Yokoyama.
    https://orcid.org/0000-0001-8508-7587
  5. International Molecular Biologist Awards. (n.d.). Award information and evaluation framework.
    https://molecularbiologist.org/

Xin Liu | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

 

Best Researcher Award

Xin Liu
Shenyang Agricultural University , China

Xin Liu
Affiliation Shenyang Agricultural University
Country China
Scopus ID 57207948842
Citations 540
h-index 12
Documents 33
Subject Area Molecular Biology
Event International Molecular Biologist Awards
ORCID 0000-0002-4155-9770

Xin Liu is a researcher affiliated with Shenyang Agricultural University, China, specializing in Molecular Biology. The researcher’s academic activities focus on biological mechanisms, molecular studies, and scientific investigations contributing to advancements in life sciences. [1]

Abstract

The Best Researcher Award recognizes scientific contributions, academic excellence, and meaningful advancement within specialized research fields. Xin Liu’s work in Molecular Biology reflects continued participation in research activities supporting biological discoveries and scientific development. [2]

Keywords

  • Molecular Biology
  • Biological Research
  • Genetic Studies
  • Life Science Innovation

Introduction

Molecular Biology examines biological processes at molecular levels, including genetic information, cellular mechanisms, and molecular interactions. Research in this discipline supports developments across biotechnology, medicine, and biological sciences. [3]

Research Profile

Xin Liu has established a research profile in Molecular Biology through scientific publications and scholarly contributions. The researcher has published 33 documents and achieved 540 citations with an h-index of 12, demonstrating engagement with the international research community. [1]

Research Contributions

  • Contribution to molecular and biological research studies.
  • Advancement of knowledge in molecular mechanisms.
  • Support for scientific progress through publications.

Publications

The researcher’s publications contribute to Molecular Biology literature through studies related to biological processes, molecular interactions, and scientific applications. These publications support continued research discussions within life sciences. [4]

Research Impact

Research impact is reflected through scientific output, citations, and contributions to the advancement of knowledge. Xin Liu’s academic record highlights involvement in Molecular Biology research and scholarly communication. [2]

Award Suitability

The Best Researcher Award recognizes researchers whose scientific activities contribute to innovation and academic progress. Xin Liu’s research background and contributions in Molecular Biology align with the objectives of international scientific recognition. [5]

Conclusion

Xin Liu represents a researcher contributing to Molecular Biology through scientific research and academic publications. The researcher’s work supports continued exploration of biological systems and molecular science.

References

  1. Elsevier. (n.d.). Scopus author details: Xin Liu, Author ID 57207948842. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57207948842
  2. ORCID. (n.d.). Xin Liu ORCID Researcher Profile.
    https://orcid.org/0000-0002-4155-9770
  3. Nature Reviews Molecular Cell Biology. (n.d.). Molecular Biology Research Overview.
    https://doi.org/10.1038/s41580-020-00301-7
  4. Oxford Academic. (n.d.). Scientific publications The Plant Cell in molecular biology.
    https://doi.org/10.1016/j.tibtech.2020.05.006
  5. International Molecular Biologist Awards. (n.d.). Award Information Portal.
    https://molecularbiologist.org/

 

Zhongxiang He | Molecular Biology | Research Excellence Award

Published on by Molecular Biologist

Dr. Zhongxiang He | Molecular Biology | Research Excellence Award

Dr. Zhongxiang He | Guizhou university | China

Dr. Zhongxiang He is an emerging researcher specializing in secure data systems and intelligent healthcare technologies. His work focuses on advanced encryption methods, privacy-preserving frameworks, and robust medical image watermarking using innovative models such as wavelet-driven architectures. He has contributed to interdisciplinary research in cloud-enabled e-health systems and information security, aiming to enhance data integrity, traceability, and confidentiality. His publications reflect a growing impact in applied cryptography and computational intelligence for real-world healthcare and digital security applications.

Research Metrics

50

40

30

20

10

0

Citations
3

Documents
2

h-index
1

        🟦 Citations    🟥 Documents    🟩 h-index


View ORCID Profile

Featured Publications

Ezra Kamunga | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Mr. Ezra Kamunga | Molecular Biology | Best Researcher Award

Research scientist | Nanjing Agriculture University | Tanzania

Mr. Ezra Kamungai is an emerging researcher specializing in aquaculture science, focusing on fish physiology, microbiota, and feed efficiency. His work contributes to understanding growth performance and sustainable fish production systems. He has authored 3 scholarly documents indexed in Scopus, receiving 9 citations across 9 documents, with an h-index of 1. His research integrates biological analysis and environmental considerations to enhance aquaculture productivity and resource optimization in modern fisheries science.

Citation Metrics (Scopus)

100

80

60

40

20

0

Citations
9

Documents
3

h-index
1

        🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Profile

Featured Publications

Laura Estrada | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Prof. Laura Estrada | Molecular Biology | Best Researcher Award 

Researcher | Physics department University of Buenos Aires | Argentina

Prof. Laura Cecilia Estrada is a physicist, educator, and researcher whose work bridges advanced optical microscopy, nanotechnology, and interdisciplinary biophysics. She serves as Adjunct Professor at the Department of Physics, University of Buenos Aires and Independent Researcher at CONICET, where she leads pioneering investigations in fluorescence spectroscopy, nanoimaging, and virus-host interactions. Estrada completed her academic training in physics at the University of Buenos Aires, earning her Licenciatura and Ph.D. with highest distinction, and later expanded her expertise as a postdoctoral researcher and group leader at the University of California, Irvine. Her research focuses on fluorescence-based techniques, single-particle tracking, and nano-optics applied to both fundamental physics and biomedical sciences, with special emphasis on dengue and Zika virus proteins. Alongside her scientific contributions, she has played key leadership roles in professional societies and gender equity initiatives. Her work has been recognized nationally and internationally, including awards from the International Commission for Optics, the Biophysical Society, and Argentina’s INNOVAR program. She has supervised numerous theses, mentored young scientists, and fostered international collaborations. With 35 publications, 325 citations, and an h-index of 9, Estrada exemplifies scientific rigor, innovation, and social commitment in advancing both knowledge and equity.

Profile: Scopus

Featured Publications

Sallaberry, I., & Estrada, L. Unraveling viral protein-host membrane interaction for dengue and Zika. Biophysical Journal.

Leon, A., Sallaberry, I., Estrada, L., & Scorticati, C. Non-synonymous SNPs within GPM6A impair hippocampal neuron development. Biochimica et Biophysica Acta, 1872(3). Cited by 2.

Salzman, V., & Estrada, L. Replicative lifespan determination of yeast using microfluidic chip. Biology Open, 13(11). Cited by 5.

Gaggioli, E., Estrada, L., & Bruno, O. Boundary layer structures in transport theory. Physical Review E, 110. Cited by 3.

Philipp, N., Gratton, E., & Estrada, L. Protein-membrane interaction via radial FCS. Methods and Applications in Fluorescence, 11(4). Cited by 12.

Gabriel, M., & Estrada, L. Dengue Virus Capsid Protein Dynamics in live cells. Scientific Reports, 10. Cited by 45.

Maria Camprubi Robles | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Maria Camprubi Robles | Molecular Biology | Best Researcher Award 

Research Scientist | Abbott Laboratories | Spain

Dr. Maria Camprubi is a highly accomplished Research Scientist with over a decade of dedicated service at Abbott Nutrition, specializing in molecular and cellular biology. With strong expertise in nutritional science, she has significantly contributed to the development of innovative products that address sarcopenia, chronic disease, and malnutrition across Europe, the Middle East, and Africa. She holds a Ph.D. in Molecular and Cellular Biology, where she built a strong foundation in cellular processes and metabolic regulation. Her academic training provided the expertise to bridge laboratory research with clinical nutrition, forming the cornerstone of her impactful scientific career.  Dr. Camprubi has worked at Abbott in the R&D department, leading projects that focus on the nutritional management of vulnerable populations. Her experience spans cross-functional collaborations, clinical trials, and translating research into practical solutions that improve health outcomes globally. Her research interests focus on nutrition metabolism to support muscle health, healthy aging, oncology, and diabetes. She aims to create evidence-based interventions that help prevent muscle decline, enhance recovery during chronic illnesses, and promote long-term well-being in aging populations. Dr. Camprubi has been recognized within Abbott for her leadership in advancing nutritional innovation. Her commitment to applying molecular and clinical insights to product development has positioned her as a leading scientist driving transformative changes in health and nutrition. She has authored impactful publications in peer-reviewed journals, contributing knowledge on nutritional metabolism, sarcopenia, and disease-related malnutrition. Her scientific contributions have achieved 1,276 citations by 1,194 documents, with 24 published documents and an h-index of 17, reflecting her influence in the scientific community and the value of her contributions to global health research.

Profile: Scopus

Featured Publications

A prospective, observational study of the effect of a high-calorie, high-protein oral nutritional supplement with HMB in an old and malnourished or at-risk-of-malnutrition population with hip fractures: A FracNut study. Nutrients, 16(8)

The vicious cycle of type 2 diabetes mellitus and skeletal muscle atrophy: Clinical, biochemical, and nutritional bases. Nutrients, 16(1), 172

Heng Zhang | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Heng Zhang | Molecular Biology | Best Researcher Award 

Lecturer | Nankai University | China

Dr. Zhang Heng is a Lecturer in Pharmacology at Nankai University, specializing in investigating the molecular mechanisms underlying malignant tumor progression and developing innovative drug therapies. He earned his B.S., M.S., and Ph.D. in Pharmaceutical Sciences from Nankai University, completing his doctoral studies with high distinction. Since joining the faculty as a lecturer, he has been actively engaged in teaching, mentoring, and advancing cutting-edge cancer research. Dr. Zhang has published multiple high-impact papers in prestigious SCI-indexed journals, including Molecular Cell, Signal Transduction and Targeted Therapy, and Advanced Materials. His scholarly contributions include original research on extrachromosomal DNA, tumor stem cell propagation, and nanomedicine-based immunotherapy. He also holds four patent applications and has received several top academic and innovation awards. Through his research and academic leadership, Dr. Zhang continues to make significant contributions toward improving the understanding of cancer biology and developing novel therapeutic strategies for clinical application.

Professional Profile

ORCID

Education

Dr. Zhang Heng pursued his higher education entirely at Nankai University, a leading institution in China recognized for excellence in pharmaceutical research. He began his academic journey with a Bachelor of Science degree in Pharmaceutical Sciences, where he built a strong foundation in pharmacology, molecular biology, and medicinal chemistry. Continuing at Nankai, he completed his Master of Science degree, focusing on the molecular biology of tumors and early drug discovery methodologies. His master’s research involved extensive laboratory experiments, including molecular cloning, protein analysis, and tumor cell line studies. Dr. Zhang then earned his Ph.D. in Pharmaceutical Sciences, conducting advanced research on the molecular mechanisms driving cancer progression and identifying new targets for therapeutic intervention. His doctoral studies resulted in multiple publications in internationally recognized journals. This academic path, marked by consistent excellence and research productivity, has equipped him with the knowledge and skills essential for his role as an independent researcher and educator.

Experience

Following the completion of his doctoral studies, Dr. Zhang Heng was appointed Lecturer at the College of Pharmacy, Nankai University. In this role, he has been responsible for delivering lectures in pharmacology, supervising undergraduate and graduate students, and leading research initiatives in molecular oncology. He has designed and managed multiple research projects, often collaborating with interdisciplinary teams, and has successfully bridged fundamental science with translational medicine. His experience encompasses conducting high-level molecular biology research, managing laboratory operations, and contributing to scientific publications as both first and corresponding author. He has filed patents for innovative drug delivery systems and tumor immunotherapies, demonstrating the applied impact of his work. Beyond laboratory research, Dr. Zhang has participated in national-level innovation competitions and academic conferences, presenting his findings to peers and experts in the field. His experience reflects a balance of teaching excellence, research innovation, and contribution to the broader scientific community.

Research Interest

Dr. Zhang Heng’s research interests lie at the intersection of cancer biology, molecular pharmacology, and drug innovation. He investigates the fundamental mechanisms that drive the malignant progression of tumors, including the role of extrachromosomal DNA, R-loop dynamics, and vasculogenic mimicry. His work also explores how specific proteins and epigenetic factors regulate tumor growth, immune evasion, and stem cell maintenance. In addition to basic research, Dr. Zhang focuses on developing new therapeutic strategies, such as tumor-targeted nanomedicines, biomimetic exosomes, and in situ tumor vaccines. He aims to integrate these novel approaches into translational medicine frameworks, ultimately leading to more effective, personalized cancer treatments. His interdisciplinary methodology combines molecular biology, pharmacology, nanotechnology, and immunotherapy, with the overarching goal of creating clinically applicable solutions for some of the most aggressive and treatment-resistant cancers. This research focus reflects both scientific curiosity and a commitment to advancing healthcare outcomes.

Award

Dr. Zhang Heng has been recognized for his outstanding research achievements, innovative contributions, and academic excellence through multiple prestigious awards. He received the Second Prize of the Tianjin Science and Technology Progress Award, which acknowledges impactful scientific advancements with practical applications. His innovative work in drug development and cancer therapy earned him the Gold Award at the China International “Internet Plus” Innovation and Entrepreneurship Competition. In recognition of his leadership, scientific merit, and contributions to society, he was awarded the Tianjin May Fourth Youth Medal. While a student, Dr. Zhang received the Zhou Enlai Scholarship, the highest honor granted by Nankai University, and was named Nankai University Student of the Year. These distinctions highlight not only his research excellence but also his dedication to innovation, community engagement, and the advancement of pharmacological sciences on both a national and international level.

Top Noted Publication

Dr. Zhang Heng has authored a series of impactful publications in high-ranking scientific journals, contributing significantly to the fields of molecular oncology and drug development. His research outputs span mechanistic cancer biology studies, novel therapeutic approaches, and the application of nanotechnology in tumor immunotherapy. These publications have been cited in multiple peer-reviewed articles, demonstrating their influence within the global scientific community. His work continues to inform and inspire ongoing research in cancer treatment innovation.

Publications list (single-line prompt):

Title: Extrachromosomal DNA biogenesis is dependent on DNA looping and religation by YY1–Lig3–PARylation complex
Journal: Molecular Cell
Year: 2025

Title: MTA2 triggered R-loop trans-regulates BDH1-mediated β-hydroxybutyrylation and potentiates propagation of hepatocellular carcinoma stem cells
Journal: Signal Transduction and Targeted Therapy
Year: 2021

Title: Biomimetic Immunosuppressive Exosomes that Inhibit Cytokine Storms Contribute to the Alleviation of Sepsis
Journal: Advanced Materials
Year: 2022

Title: Magnetic sculpture-like tumor cell vaccines enable targeted in situ immune activation and potent antitumor effects
Journal: Theranostics
Year: 2025

Title: Vitamin D binding protein (VDBP) hijacks Twist1 to inhibit vasculogenic mimicry in hepatocellular carcinoma
Journal: Theranostics
Year: 2024

Conclusion

Dr. Zhang Heng is a highly suitable candidate for the Research for Best Researcher Award. His combination of scientific excellence, innovation, and societal impact aligns well with the award’s criteria. With continued growth in global collaboration and academic leadership, he has the potential to become a leading figure in pharmacology and cancer research worldwide.

 

Ingrid Tatiana Erazo | Molecular Biology | Molecular Biology Contribution Award

Published on by Molecular Biologist

Dr. Ingrid Tatiana Erazo | Molecular Biology | Molecular Biology Contribution Award 

Scientific Research Lead | Memorial Sloan Kettering Cancer Center | United States

Dr. Ingrid Tatiana Erazo is a distinguished cancer researcher and Scientific Research Lead at Memorial Sloan Kettering Cancer Center (MSKCC) with extensive experience in translational oncology. She earned her PhD Summa Cum Laude in Biochemistry and Molecular Biology from the Autonomous University of Barcelona, where she pioneered research on the ERK5 signaling pathway. Her early postdoctoral work led to the discovery of the mechanism of action for ABTL-0812, an autophagy-inducing anticancer agent now in Phase III clinical trials. Over the past decade at MSKCC, she has advanced understanding of PRMT5 inhibition, therapeutic resistance, and biomarker development for precision oncology. She currently leads initiatives integrating liquid biopsy diagnostics for early cancer detection and is spearheading global health equity programs, including the creation of Brazil’s first national referral network for cancer clinical trials. Her work bridges molecular discoveries with clinical application, driving advancements in both targeted therapies and diagnostic tools.

Professional Profile

Scopus

ORCID

Google Scholar

Education

Dr. Erazo earned her PhD in Biochemistry and Molecular Biology from the Autonomous University of Barcelona, graduating Summa Cum Laude. Her doctoral research focused on dissecting the ERK5 signaling pathway and its role in cancer cell proliferation and survival. She used Tandem Affinity Purification to map ERK5’s interactome, uncovering novel noncanonical mechanisms and post-translational modifications such as SUMOylation that opened new therapeutic opportunities. Collaborating with Dana-Farber Cancer Institute at Harvard, she co-developed potent and selective ERK5 inhibitors, providing valuable pharmacological tools for cancer research. Her academic training combined molecular biology with translational oncology, giving her a unique foundation to move seamlessly from bench research to clinical applications. She also pursued advanced training in biomarker discovery and molecular diagnostics, enabling her to contribute to projects that merge fundamental discoveries with practical solutions for cancer detection, prognosis, and treatment optimization in a variety of clinical contexts.

Experience

Dr. Erazo’s professional career spans more than 20 completed research projects and leadership in multiple ongoing studies, covering molecular oncology, biomarker discovery, and therapeutic resistance. At MSKCC, she elucidated the mechanism of action of PRMT5 inhibitors and identified MUSASHI-2 as a driver of drug resistance in hematologic malignancies, leading to innovative combination therapy strategies. She developed liquid biopsy-based diagnostics for aggressive prostate cancers and integrated proteomic biomarkers into clinical research pipelines. In her earlier postdoctoral role at Ability Pharmaceuticals, she was instrumental in advancing ABTL-0812 to clinical trials by defining its mechanism and identifying relevant biomarkers. She has partnered with global pharmaceutical and biotech companies, including GlaxoSmithKline, Biodesix Inc., and Guardant Health. Her work also extends to global health initiatives, such as establishing Brazil’s first national referral network for cancer clinical trials with molecular profiling, aiming to address disparities in cancer care and ensure equitable access to precision oncology.

Research Interest

Dr. Erazo’s research focuses on cancer biology, mechanisms of drug resistance, biomarker discovery, and precision oncology. She has a particular interest in hematological malignancies and aggressive solid tumors where therapeutic resistance significantly impacts patient outcomes. Her work applies genome-wide CRISPR synthetic lethal screening, proteomics, and high-throughput drug screening to identify cancer vulnerabilities and inform new treatment strategies. She is advancing diagnostic methods through liquid biopsy technology, enabling early and non-invasive tumor detection and monitoring, with a focus on neuroendocrine prostate cancer. Dr. Erazo also addresses global health inequities by developing clinical trial networks in underrepresented regions and incorporating genetic ancestry into study designs to improve population-specific therapeutic approaches. By combining basic molecular research with translational and clinical applications, she aims to ensure that future cancer therapies and diagnostics are effective across diverse populations and accessible beyond high-resource healthcare settings.

Awards

Dr. Erazo’s scientific achievements have positioned her as a leader in translational cancer research and a nominee for the Molecular Biology Contribution Award. She is recognized for her groundbreaking work on ERK5 signaling, the clinical biomarker development for ABTL-0812, and the identification of MUSASHI-2 as a therapeutic resistance driver. Her contributions to liquid biopsy-based proteomic biomarkers for detecting lineage transformation in prostate cancer have advanced early diagnostic capabilities in precision oncology. She has also been a driving force behind the establishment of Brazil’s first national clinical trial referral network, demonstrating a strong commitment to global health equity. Her work, cited extensively in scientific literature, reflects both scientific rigor and real-world clinical impact. These accomplishments highlight her role as both a laboratory innovator and a global health strategist, whose research has shaped cancer treatment strategies and advanced diagnostic development on an international scale.

Top Noted Publications

Dr. Erazo has authored over 20 peer-reviewed articles in high-impact journals, including Annals of Oncology, Nature Communications, Autophagy, and Clinical Cancer Research. Her research spans mechanistic cancer biology, drug development, and biomarker-driven clinical applications. She has contributed to significant discoveries such as mapping the ERK5 interactome, elucidating the mechanism of action for ABTL-0812, and identifying resistance biomarkers for hematological malignancies. Her publications often emerge from collaborative projects that integrate molecular biology, pharmacology, and clinical trial data, reflecting her multidisciplinary approach to advancing oncology research. The high citation count of her work underscores its influence and the adoption of her findings by researchers and clinicians worldwide. Her studies have informed clinical trial design, therapeutic development, and diagnostic tool implementation, bridging the gap between basic science and patient-centered outcomes in cancer care.

Selected Publications (Single-Line Format)

Title: Erazo T, et al. The new antitumor drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by increasing dihydroceramide levels
Journal: Nature Communications
Cited by 312

Title: Erazo T, et al. Inhibition of PRMT5 in lymphomas overcomes therapeutic resistance via MUSASHI-2 modulation
Journal: Clinical Cancer Research
Cited by 145

Title: Erazo T, et al. ERK5 kinase activity-independent functions in cancer: implications for drug development
Journal: Autophagy
Cited by 110

Title: Erazo T, et al. Blood-based proteomic biomarkers for early detection of lineage plasticity in prostate cancer
Journal: Annals of Oncology
Cited by 35

Title: Erazo T, et al. High-throughput screening of FDA-approved drugs for novel therapeutic combinations in lymphoma
Journal: Molecular Oncology
Cited by 28

Conclusion

Dr. Ingrid Tatiana Erazo’s pioneering research, translational breakthroughs, and commitment to equitable precision oncology position her as an outstanding candidate for the Research for Molecular Biology Contribution Award. Her work exemplifies how rigorous molecular biology can directly shape novel therapeutics, diagnostics, and healthcare systems globally. Awarding her would recognize not only her individual achievements but also her vision for transforming cancer care through innovation and inclusivity.